Mylan CEO defends EpiPen pricing in congressional hearing
Wednesday, September 21, 2016 - 19:51
in Mathematics & Economics
Kelly Norris, Medill News ServiceWASHINGTON, D.C. -- Mylan CEO Heather Bresch on Wednesday defended her company's EpiPen pricing, telling a House committee that a cheaper generic version should be available soon.